NOS2 and ovarian carcinoma: In human epithelial ovarian cancer, the use of cisplatin, an alkylating‐like agent used in ovarian cancer chemotherapy 3, results in iNOS up‐regulation, but eNOS down‐regulation of expression, suggesting a pivotal role of iNOS in this disease 5.